Comparison · NCT03509350-8c83df3c
Treatment Protocol vs Control Protocol: Mortality at 30 Days
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Treatment Protocol vs Control Protocol: Mortality at 30 Days. Trial comparisons, record NCT03509350-8c83df3c. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03509350-8c83df3c
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.222 | 0.175 | 0.278 | wilson | |
| Risk in group 2 | 0.241 | 0.192 | 0.298 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0187 | -0.0924 | 0.0551 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.922 | 0.67 | 1.27 | log | |
| Odds ratio, group 1 over group 2 | 0.9 | 0.594 | 1.36 | log | |
| Number needed to treat, for one fewer participant with the outcome on Treatment Protocol than on Control Protocol | 53.4 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Treatment Protocol | Participants randomized to the treatment protocol received the VICTAS Intervention, consisting of intravenous vitamin C, thiamine, and hydrocortisone for four days or until ICU discharge. | 56 | 252 | OG000 |
| Group 2 | Control Protocol | Participants in the control group received a placebo to match the VICTAS intervention, which was administered for four days or until ICU discharge. | 60 | 249 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Mortality at 30 Days
- Description
- The number of participants who did not survive until Day 30 is compared between study arms.
- Time frame
- Day 30
- Population
Source ClinicalTrials.gov
Trial
- Title
- Vitamin C, Thiamine, and Steroids in Sepsis
- NCT number
- NCT03509350
- Phases
- PHASE3
- Conditions
- Sepsis
- Interventions
- Vitamin C, Thiamine, Hydrocortisone, Vitamin C Placebo, Thiamine Placebo, Hydrocortisone Placebo
- Lead sponsor
- Emory University
- Results first posted
- 2020-09-18
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03509350?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03509350-8c83df3c